Andrej Jedinak

1.1k total citations
25 papers, 892 citations indexed

About

Andrej Jedinak is a scholar working on Pharmacology, Molecular Biology and Complementary and alternative medicine. According to data from OpenAlex, Andrej Jedinak has authored 25 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 8 papers in Molecular Biology and 7 papers in Complementary and alternative medicine. Recurrent topics in Andrej Jedinak's work include Fungal Biology and Applications (11 papers), Medicinal plant effects and applications (6 papers) and Phytochemistry and Bioactivity Studies (5 papers). Andrej Jedinak is often cited by papers focused on Fungal Biology and Applications (11 papers), Medicinal plant effects and applications (6 papers) and Phytochemistry and Bioactivity Studies (5 papers). Andrej Jedinak collaborates with scholars based in United States. Andrej Jedinak's co-authors include Daniel Slíva, Shailesh Dudhgaonkar, Jiahua Jiang, Marsha A. Moses, Veronika Slivova, Colin Terry, James H. Simon, Qingli Wu, Lee Ann Baldridge and Roopali Roy and has published in prestigious journals such as PLoS ONE, Cancer Research and The FASEB Journal.

In The Last Decade

Andrej Jedinak

24 papers receiving 870 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrej Jedinak United States 15 434 351 169 161 109 25 892
Anita Thyagarajan United States 15 453 1.0× 359 1.0× 194 1.1× 165 1.0× 149 1.4× 50 992
Youn Kyung Choi South Korea 19 440 1.0× 152 0.4× 93 0.6× 157 1.0× 92 0.8× 36 957
Bum‐Sang Shim South Korea 15 446 1.0× 142 0.4× 123 0.7× 107 0.7× 160 1.5× 39 926
Veronika Slivova United States 12 316 0.7× 513 1.5× 234 1.4× 136 0.8× 167 1.5× 16 903
Lalitha Ramachandran Singapore 8 557 1.3× 121 0.3× 130 0.8× 197 1.2× 122 1.1× 11 1.0k
Sheryl Phung United States 20 530 1.2× 183 0.5× 80 0.5× 269 1.7× 57 0.5× 32 1.2k
Jiong Zhao United States 16 484 1.1× 199 0.6× 92 0.5× 108 0.7× 50 0.5× 25 952
Yi‐Ching Chuang Taiwan 19 532 1.2× 106 0.3× 111 0.7× 114 0.7× 132 1.2× 56 869
Sen Lian South Korea 19 491 1.1× 125 0.4× 83 0.5× 149 0.9× 60 0.6× 28 928

Countries citing papers authored by Andrej Jedinak

Since Specialization
Citations

This map shows the geographic impact of Andrej Jedinak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrej Jedinak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrej Jedinak more than expected).

Fields of papers citing papers by Andrej Jedinak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrej Jedinak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrej Jedinak. The network helps show where Andrej Jedinak may publish in the future.

Co-authorship network of co-authors of Andrej Jedinak

This figure shows the co-authorship network connecting the top 25 collaborators of Andrej Jedinak. A scholar is included among the top collaborators of Andrej Jedinak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrej Jedinak. Andrej Jedinak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lakshmikanthan, Sribalaji, et al.. (2020). Abstract 2239: Intratumoral delivery of mPH-804 (TIGIT targeting INTASYL compound) inhibits tumor growth and confers an inflammatory tumor microenvironment. Cancer Research. 80(16_Supplement). 2239–2239. 1 indexed citations
2.
Roy, Roopali, Golnaz Morad, Andrej Jedinak, & Marsha A. Moses. (2019). Metalloproteinases and their roles in human cancer. The Anatomical Record. 303(6). 1557–1572. 52 indexed citations
4.
Yang, Jiang, Roopali Roy, Andrej Jedinak, & Marsha A. Moses. (2015). Mining the Human Proteome. The Cancer Journal. 21(4). 327–336. 12 indexed citations
5.
Jedinak, Andrej, Adam S. Curatolo, David Zurakowski, et al.. (2015). Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancer. BMC Cancer. 15(1). 259–259. 43 indexed citations
6.
Loganathan, Jagadish, Jiahua Jiang, Amanda M. Smith, et al.. (2014). The mushroom Ganoderma lucidum suppresses breast-to-lung cancer metastasis through the inhibition of pro-invasive genes. International Journal of Oncology. 44(6). 2009–2015. 38 indexed citations
7.
Slíva, Daniel, Jagadish Loganathan, Jiahua Jiang, et al.. (2012). Mushroom Ganoderma lucidum Prevents Colitis-Associated Carcinogenesis in Mice. PLoS ONE. 7(10). e47873–e47873. 57 indexed citations
8.
Jiang, Jiahua, et al.. (2012). NAHA, a Novel Hydroxamic Acid-Derivative, Inhibits Growth and Angiogenesis of Breast Cancer In Vitro and In Vivo. PLoS ONE. 7(3). e34283–e34283. 36 indexed citations
9.
Jiang, Jiahua, Veronika Slivova, Andrej Jedinak, & Daniel Slíva. (2011). Gossypol inhibits growth, invasiveness, and angiogenesis in human prostate cancer cells by modulating NF-κB/AP-1 dependent- and independent-signaling. Clinical & Experimental Metastasis. 29(2). 165–178. 40 indexed citations
10.
Jedinak, Andrej, Shailesh Dudhgaonkar, Qingli Wu, James H. Simon, & Daniel Slíva. (2011). Anti-inflammatory activity of edible oyster mushroom is mediated through the inhibition of NF-κB and AP-1 signaling. Nutrition Journal. 10(1). 52–52. 105 indexed citations
11.
Jedinak, Andrej, Shailesh Dudhgaonkar, Mark R. Kelley, & Daniel Slíva. (2011). Apurinic/Apyrimidinic endonuclease 1 regulates inflammatory response in macrophages.. PubMed. 31(2). 379–85. 48 indexed citations
12.
Jiang, Jiahua, Andrej Jedinak, & Daniel Slíva. (2011). Ganodermanontriol (GDNT) exerts its effect on growth and invasiveness of breast cancer cells through the down-regulation of CDC20 and uPA. Biochemical and Biophysical Research Communications. 415(2). 325–329. 77 indexed citations
13.
Thyagarajan, Anita, Andrej Jedinak, Nguyen Hai Dang, et al.. (2010). Triterpenes FromGanoderma LucidumInduce Autophagy in Colon Cancer Through the Inhibition of p38 Mitogen-Activated Kinase (p38 MAPK). Nutrition and Cancer. 62(5). 630–640. 105 indexed citations
14.
Jiang, Jiahua, et al.. (2010). Suppression of Proliferation and Invasive Behavior of Human Metastatic Breast Cancer Cells by Dietary Supplement BreastDefend. Integrative Cancer Therapies. 10(2). 192–200. 10 indexed citations
15.
Jedinak, Andrej, Shailesh Dudhgaonkar, & Daniel Slíva. (2009). Activated macrophages induce metastatic behavior of colon cancer cells. Immunobiology. 215(3). 242–249. 84 indexed citations
17.
Slíva, Daniel, et al.. (2008). Phellinus linteus suppresses growth, angiogenesis and invasive behaviour of breast cancer cells through the inhibition of AKT signalling. Publisher. 4 indexed citations
18.
Thyagarajan, Anita, Hai Xuan Nguyen, Andrej Jedinak, & Daniel Slíva. (2008). Inhibition of colon cancer cells by Ganoderma lucidum triterpenes.. Cancer Research. 68. 5472–5472. 1 indexed citations
19.
Slíva, Daniel, et al.. (2008). Phellinus linteus suppresses growth, angiogenesis and invasive behaviour of breast cancer cells through the inhibition of AKT signalling. British Journal of Cancer. 98(8). 1348–1356. 82 indexed citations
20.
Jedinak, Andrej & Daniel Slíva. (2008). Pleurotus ostreatus inhibits proliferation and modulates expression of cell cycle regulatory proteins in human breast and colon cancer cells. The FASEB Journal. 22(S2). 758–758. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026